Bladder drugs and risk of dementia: Danish nationwide active comparator study
In this study, all types of anticholinergic bladder drugs were associated with an increased risk of dementia compared with non-use, but not when applying the active comparator of the β3 agonist bladder drug mirabegron. These findings highlight the relevance of using an active comparator. Future research should evaluate the risk of cognitive impairment and dementia for both types of bladder drugs.
Authors
- Gunhild Waldemar (ORCID: https://orcid.org/0000-0003-0293-220X)
- Amani Meaidi (ORCID: https://orcid.org/0000-0003-4549-8271)
- Thomas Munk Laursen (ORCID: https://orcid.org/0000-0001-6934-1784)
- Nelsan Pourhadi (ORCID: https://orcid.org/0000-0002-5647-1018)
- Christina Jensen‐Dahm (ORCID: https://orcid.org/0000-0001-7946-6556)
- Janet Janbek (ORCID: https://orcid.org/0000-0003-1605-3396)
- Christiane Gasse (ORCID: https://orcid.org/0000-0001-6194-1099)
Institutions
- University of Copenhagen (DK)
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Danish Cancer Society (DK)
Publication Details
- Journal
- BMJ Medicine
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1136/bmjmed-2024-001125
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.84
Funders
- Gentofte Hospital
- Rigshospitalet
- Ministeriet Sundhed Forebyggelse